Fortis Healthcare Ltd (FORTIS) is currently trading at 790.90 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Fortis Healthcare is an integrated Indian private healthcare provider operating 36 hospitals, approximately 6,100 operational beds and 400+ diagnostics centres as of March 31, 2026, delivering multi‑specialty inpatient, outpatient and ancillary services through its Fortis hospitals and SRL diagnostics verticals across major Indian cities. Management reported a Delhi High Court order directing a forensic audit covering complex historical promoter and transaction matters from 2018–2026, with a court timeline calling for initial information requests within weeks and a forensic report within six months; management says operations and strategic plans remain unaffected. IHH Healthcare, Fortis Healthcare’s strategic investor, publicly reiterated commitment to Fortis, including capital support and potential integration with Gleneagles, indicating continued parent backing that materially reduces execution risk on growth, M&A, and capacity expansion initiatives. Fortis executed material network growth in FY2025–26 — adding ~800 beds, multiple acquisitions, brownfield capacity and specialty launches like Adayu mental healthcare — signalling accelerated inorganic and organic expansion that will drive near‑term revenue and service diversification. Diagnostics is a core pillar: Fortis holds a fully diluted ~56.6% stake in SRL Limited, and the company has continued to expand diagnostics capabilities and advanced tests, positioning Fortis to capture higher ancillary revenue and operational synergies across hospitals and diagnostic centres.

Over the past 52 weeks, Fortis Healthcare Ltd has traded between a low of ₹704.55 and a high of ₹1,030.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Fortis Healthcare Ltd has a market capitalization of approximately 59,226.47. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Fortis Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 55.34 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 59,226.47 Cr, Fortis Healthcare Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Fortis Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Fortis Healthcare Ltd is 55.34. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Fortis Healthcare acquired Suguna Hospital's business, land and building for approximately ₹277 crore in an all-cash transaction.

Fortis Healthcare is scheduled to announce its Q1 FY27 (June quarter) financial results on August 6, 2026, following a board meeting to approve the unaudited numbers.

Fortis Healthcare reported FY26 consolidated revenue from operations of ₹9,127.84 crore and profit for the year of ₹1,064.19 crore.

Officials said a complaint during a CM public hearing alleged delayed emergency treatment and a demand for money before care, leading to an inspection that flagged multiple discrepancies.